# Phenotypic and Genetic Properties in Males at Risk for X-linked Hypohidrotic Ectodermal Dysplasia: Evaluation of an Early Diagnosis Technology and Tests to Assess Nutritional Status

> **NCT01629940** · — · COMPLETED · sponsor: **Edimer Pharmaceuticals** · enrollment: 36 (actual)

## Conditions studied

- X-linked Hypohidrotic Ectodermal Dysplasia
- Hypohidrotic Ectodermal Dysplasia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01629940
- **Lead sponsor:** Edimer Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2012-07
- **Final completion:** 2012-10
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2012-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01629940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01629940, "Phenotypic and Genetic Properties in Males at Risk for X-linked Hypohidrotic Ectodermal Dysplasia: Evaluation of an Early Diagnosis Technology and Tests to Assess Nutritional Status". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01629940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*